Bacterial Infections and Mycoses

318 trials 133 recruiting

Filter these 318 trials by phase, country and sponsor.

Open in Search →

A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting

2022-500257-16-00 Diabetic Foot Infections 5 2023-03-17
Effects of mesenchymal stem cells administration on organ failure during septic shock: Phase II randomized comprator-controlled study CHOC-M… Recruiting

2024-518019-20-00 La population concernée est celle des patients hospital 4 2021-10-19
A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients wit… Recruiting

2026-525619-15-00 Bacterial Infection 1 2026-05-22
TRI-AB trial Recruiting

2024-520251-24-00 Complicated urinary tract infections (cUTI) requiring h 6 2026-05-04
Clindamycin as an alternative to vancomycin in patients undergoing aortic cardiac surgery with extracorporeal circulation (ECC): a prospecti… Recruiting

2025-521555-23-00 Patients undergoing cardiac surgery with extracorporeal 4 2026-04-21
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Infective Endocarditis 6 2026-03-30
A phase I study investigating the local tolerability and pharmacokinetics of isoniazid (INH) inhalation by wet nebulization in patients with… Recruiting

2024-517793-25-00 Tuberculosis 1 2026-03-30
Prevention of Recurrent C. difficile Infection Study with AZD5148 Monoclonal Antibody Recruiting

2025-521416-19-00 Recurrence of Clostridioides difficile Infection 4 2026-03-12
Changes in the wound microbiome and their impact on chronic wound healing under hyperbaric conditions Recruiting

2025-523863-39-00 chronic wounds 6 2026-03-05
A Phase I study to evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects Recruiting

2025-523108-59-00 Severe infections caused by Gram-negative bacteria 1 2026-03-04
Single-centre clinical trial investigating safety and tolerability of repeated administrations of increasing doses of nebulised SS0331 in he… Recruiting

2025-523875-48-00 Chronic airway infections 9 2026-02-17
Clinical trial in multiple hospitals to explore new ways to diagnose and monitor tuberculosis treatment Recruiting

2025-522235-34-00 Bacterial pneumonia patients 6 2026-02-11
A Randomized controlled open-label phase II trial assessing the efficacy and safety of two-dosing regimens of frozen encapsulated fecal micr… Recruiting

2024-519748-34-00 Infections with multidrug-resistant Enterobacteriaceae 4 2026-01-23
A Study to Learn About Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants Recruiting

2022-503070-36-00 Group B streptococcus (GBS) disease 5 2025-12-23
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT. Recruiting

2024-517002-28-01 graft-versus-host disease 3 2025-12-17
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Periprosthetic joint infection 6 2025-12-12
Unbound Cloxacillin Concentrations During Continuous Infusion Recruiting

2023-510423-30-00 Staphylococcus aureus infection 6 2025-12-12
A double-blind, multi-centre, randomized, placebo-controlled cross-over clinical trial to assess the efficacy of doxyPEP in reducing the inc… Recruiting

2025-521153-16-00 bacterial sexually transmitted infections 5 2025-12-05
PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a no… Recruiting

2024-518583-13-00 Patients with bacteremia 6 2025-11-18
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 febrile Urinary Tract Infection (fUTI) 4 2025-11-13
Pneumoccocal vaccine response in patients without a spleen, vaccinated before or after spleen removal. Recruiting

2024-515363-63-00 Asplenia 6 2025-11-07
AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-labe… Recruiting

2023-506843-40-00 Mycobacterium xenopi pulmonary infection 5 2025-10-29
(Pre-BCGvacc) BCG vaccination: can pre-vaccination immune status predict outcome? Recruiting

2024-514428-18-00 health volunteerst 11 2025-10-24
Clinical trial to evaluate the efficacy and safety of the topical application of Impetine® Gel (mupirocin 20 mg/g) compared with Bactroban® … Recruiting

2024-517475-20-00 Impetigo 5 2025-10-13